1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Gregory Graf, PhD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ezetimibe-Ursodiol Combination Therapy on Biomarkers of Liver Function and Sterol Balance in Subjects With NAFLD EZ-Urso combination therapy - Nonalcoholic Fatty Liver Disease (NAFLD) | Phase 2 | Terminated | Gregory Graf, PhD | 2 | 2014-09-01 | 2018-02-07 |
Non-alcoholic Fatty Liver Disease (1)
Ezetimibe (1) · Ursodeoxycholic Acid (1)
United States (1)